Ethnic Differences Among Implantable Cardioverter Defibrillators Recipients in Israel

• Published in: The American journal of cardiology Vol. 115; no. 8; pp. 1102 - 1106
• Main Authors: Sabbag, Avi, Suleiman, Mahmoud, Glick, Aharon, Medina, Aharon, Golovchiner, Gregory, Steiner, Hillel, Arad, Michael, Goldenberg, Ilan, Glikson, Michael, Beinart, Roy
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 15.04.2015; Elsevier Limited
• Subjects: Age; Aged; Arab people; Cardiac arrhythmia; Cardiomyopathy; Cardiovascular; Cardiovascular disease; Cause of Death - trends; Death, Sudden, Cardiac - ethnology; Death, Sudden, Cardiac - prevention & control; Defibrillators, Implantable; Diabetes; Disease prevention; Diuretics; Ethnic Groups; Ethnicity; Family medical history; Female; Follow-Up Studies; Heart attacks; Heart failure; Heart Failure - ethnology; Heart Failure - therapy; Humans; Israel - epidemiology; Jewish people; Male; Middle Aged; Mortality; Multivariate analysis; Population; Prevalence; Prognosis; Prospective Studies; Survival Rate - trends; Variables; Israel
• ISSN: 0002-9149; 1879-1913; 1879-1913
• DOI: 10.1016/j.amjcard.2015.01.538

Heart failure is an increasingly common condition arising from a variety of different pathophysiological processes. Little is known about the unique features of Israeli Arabs who present with heart failure and who undergo cardiac device implantation. The study population comprised of 4,671 patients who were enrolled in the national Israeli Implantable Cardioverter Defibrillator registry. We compared demographic, clinical, and echocardiographic characteristics; device-related indications; and outcomes between Israeli Arabs (n = 733) and Jews (n = 3,938), who were enrolled in the registry from July 2010 through December 2013. Israeli Arabs constituted 15.7% of the study population. They were younger at presentation compared with Jews (57 ± 15 vs 66 ± 12 years, respectively; p <0.001), with a greater burden of co-morbidities, including diabetes mellitus and chronic obstructive lung disease and smoking. In addition, Arab patients had a greater frequency of non-ischemic cardiomyopathy (40.2% vs 24.6%, respectively; p <0.001), which was associated with a greater frequency of familial history of sudden cardiac death. During 15 ± 9 month follow-up, the mortality rates and appropriate device therapy were similar in both ethnic groups. In conclusion, Israeli Arab patients implanted with implantable cardioverter defibrillators display unique clinical features with greater prevalence of non-ischemic cardiomyopathy characterized by an early-onset and rapid deterioration.